Search details
1.
Risk of colorectal polyps and of malignancies in asymptomatic carriers of mutations in the main DNA mismatch repair genes.
Scand J Gastroenterol
; 53(1): 31-37, 2018 Jan.
Article
in English
| MEDLINE | ID: mdl-29025352
2.
Novel agent-based salvage autologous stem cell transplantation for relapsed multiple myeloma.
Ann Hematol
; 96(12): 2071-2078, 2017 Dec.
Article
in English
| MEDLINE | ID: mdl-29063955
3.
Inverse probability weighting to estimate causal effect of a singular phase in a multiphase randomized clinical trial for multiple myeloma.
BMC Med Res Methodol
; 16(1): 150, 2016 11 09.
Article
in English
| MEDLINE | ID: mdl-27829371
4.
Bortezomib-based therapy combined with high cut-off hemodialysis is highly effective in newly diagnosed multiple myeloma patients with severe renal impairment.
Am J Hematol
; 90(7): 647-52, 2015 Jul.
Article
in English
| MEDLINE | ID: mdl-25858483
5.
Bortezomib-thalidomide-dexamethasone is superior to thalidomide-dexamethasone as consolidation therapy after autologous hematopoietic stem cell transplantation in patients with newly diagnosed multiple myeloma.
Blood
; 120(1): 9-19, 2012 Jul 05.
Article
in English
| MEDLINE | ID: mdl-22498745
6.
Bortezomib and dexamethasone as salvage therapy in patients with relapsed/refractory multiple myeloma: analysis of long-term clinical outcomes.
Ann Hematol
; 93(1): 123-8, 2014 Jan.
Article
in English
| MEDLINE | ID: mdl-23864035
7.
Bortezomib- and thalidomide-induced peripheral neuropathy in multiple myeloma: clinical and molecular analyses of a phase 3 study.
Am J Hematol
; 89(12): 1085-91, 2014 Dec.
Article
in English
| MEDLINE | ID: mdl-25159313
8.
Prognostic relevance of 18-F FDG PET/CT in newly diagnosed multiple myeloma patients treated with up-front autologous transplantation.
Blood
; 118(23): 5989-95, 2011 Dec 01.
Article
in English
| MEDLINE | ID: mdl-21900189
9.
Role of serum free light chain assay in the detection of early relapse and prediction of prognosis after relapse in multiple myeloma patients treated upfront with novel agents.
Haematologica
; 102(3): e104-e107, 2017 03.
Article
in English
| MEDLINE | ID: mdl-27909220
10.
A comparative analysis of biosimilar vs. originator filgrastim in combination with plerixafor for stem cell mobilization in lymphoma and multiple myeloma: a propensity-score weighted multicenter approach.
Am J Hematol
; 92(9): E557-E559, 2017 Sep.
Article
in English
| MEDLINE | ID: mdl-28612372
11.
Lymph node micrometastasis and survival of patients with Stage I (Dukes' A) colorectal carcinoma.
Scand J Gastroenterol
; 46(7-8): 881-6, 2011 Jul.
Article
in English
| MEDLINE | ID: mdl-21492052
12.
Peripheral neuropathy induced by subcutaneous bortezomib-based induction therapy for newly diagnosed multiple myeloma.
Haematologica
; 99(11): e242-3, 2014 Nov.
Article
in English
| MEDLINE | ID: mdl-25085360
13.
Relative role of APC and MUTYH mutations in the pathogenesis of familial adenomatous polyposis.
Scand J Gastroenterol
; 44(9): 1092-100, 2009.
Article
in English
| MEDLINE | ID: mdl-19593690
14.
Survival, surgical management and perioperative mortality of colorectal cancer in the 21-year experience of a specialised registry.
Int J Colorectal Dis
; 24(7): 777-88, 2009 Jul.
Article
in English
| MEDLINE | ID: mdl-19280201
15.
Myeloperoxidase-positive cell infiltration in colorectal carcinogenesis as indicator of colorectal cancer risk.
Cancer Epidemiol Biomarkers Prev
; 17(9): 2291-7, 2008 Sep.
Article
in English
| MEDLINE | ID: mdl-18768495
16.
Extracellular ATP induces apoptosis through P2X7R activation in acute myeloid leukemia cells but not in normal hematopoietic stem cells.
Oncotarget
; 8(4): 5895-5908, 2017 Jan 24.
Article
in English
| MEDLINE | ID: mdl-27980223
17.
Attenuated polyposis of the large bowel: a morphologic and molecular approach.
Fam Cancer
; 16(2): 211-220, 2017 04.
Article
in English
| MEDLINE | ID: mdl-27783336
18.
Prognostic impact of serial measurements of serum-free light chain assay throughout the course of newly diagnosed multiple myeloma treated with bortezomib-based regimens.
Leuk Lymphoma
; 57(9): 2058-64, 2016 09.
Article
in English
| MEDLINE | ID: mdl-26763357
19.
The genetic and genomic background of multiple myeloma patients achieving complete response after induction therapy with bortezomib, thalidomide and dexamethasone (VTD).
Oncotarget
; 7(9): 9666-79, 2016 Mar 01.
Article
in English
| MEDLINE | ID: mdl-26575327
20.
PET/CT Improves the Definition of Complete Response and Allows to Detect Otherwise Unidentifiable Skeletal Progression in Multiple Myeloma.
Clin Cancer Res
; 21(19): 4384-90, 2015 Oct 01.
Article
in English
| MEDLINE | ID: mdl-26078390